doctor, PhD. student, University Hospital Martin / Jessenius Faculty of Medicine,Slovakia
Branislav Šlenker, MD, is a dedicated pediatrician and researcher from Slovakia, passionately engaged in the fields of Pediatric Immunology and Pediatric Rheumatology. Currently advancing his expertise as a Ph.D. student and pediatric specialist at the Department of Pediatrics, Jessenius Faculty of Medicine, Comenius University in Bratislava, Dr. Šlenker demonstrates a strong commitment to improving the management of hereditary periodic fever syndromes in children and adults.
Publication Profile
ORCID
Education Background 🎓
Dr. Šlenker’s academic journey began at Gymnázium V.B.N. in Prievidza (2012–2016), followed by completing his degree in General Medicine at the Jessenius Faculty of Medicine, Comenius University in Bratislava (2016–2022). He is presently pursuing his Ph.D. in Pediatrics, focusing on biological therapies for hereditary periodic fever syndromes, while simultaneously undergoing pediatric specialization training at the same institution.
Professional Experience 💼
Since 2022, Dr. Šlenker has been a valued member of the Department of Pediatrics at Jessenius Faculty of Medicine, Comenius University. His professional interests primarily revolve around Pediatrics, Pediatric Immunology, and Pediatric Rheumatology. In addition to his clinical and academic responsibilities, he further broadened his expertise through a prestigious preceptorship on Hereditary Angioedema at Charité – Universitätsmedizin Berlin, Germany, in September 2022.
Awards and Honors 🏆
While formal awards are not listed at this stage of his career, Dr. Šlenker’s acceptance into competitive programs such as the international preceptorship at Charité and his active role in leading-edge pediatric research highlights his distinction and recognition within the academic and medical communities.
Research Focus 🔬
Dr. Šlenker’s primary research concentrates on “Selected clinical and laboratory aspects of biological therapy in the management of hereditary periodic fever syndromes,” with a particular focus on pediatric and adult patients. His work seeks to uncover safer and more effective treatment pathways, improving the quality of life for individuals suffering from these rare autoinflammatory conditions.
Conclusion 📚
Branislav Šlenker, MD, is a promising young clinician and researcher whose dedication to pediatric immunology and rheumatology, combined with his commitment to innovative biological therapies, positions him as a future leader in pediatric healthcare advancements. His dynamic career reflects a balance of academic excellence, clinical dedication, and research-driven passion.
📑 Publication Top Notes:
Is Canakinumab Safe During Pregnancy? New Insights from Three Cases in Slovakia
🔗 Link to publication
📅 Published Year: 2023
📰 Journal: Clinical Reviews in Allergy & Immunology
📈 Cited by: 3 articles (as per Google Scholar records)